Assessment of major gaps from the perspective of patients, patient advocates and NET health care professionals.
Due to the increasing incidence and prevalence of neuroendocrine tumors (NETs), there is a need to assess any gaps in awareness and care. A survey was undertaken in 2017 to identify perceived unmet needs from the perspectives of patients/families, patient advocates and health care professionals (HCPs). The survey consisted of 33–37 questions (depending on type of respondent) across four areas: information, care, treatments and research.
Recent News
Cancer52 Showcase Video response to the Covid-19 pandemic
Delighted to launch the Cancer52 video showcasing the amazing work of Cancer52 members in response to the Covid-19 pandemic. The Showcase Video highlights the innovation and tenacity of our members in the face of the extraordinary challenges of the past couple of...
Incidence and survival of neuroendocrine neoplasia in England 1995–2018
NEW : Neuroendocrine Cancers - why data matters Incidence and Prevalence of Neuroendocrine Cancers in England 1995-2018. This comprehensive whole population analysis of NEN is to our knowledge the largest in Europe to date. Between 1995 and 2018, in England, the...
10th Annual INCA (International Neuroendocrine Cancer Alliance) Global Patient Advocate Summit
The NET patient community has finally met in-person after 3 years at the 10th Annual INCA (International #Neuroendocrine Cancer Alliance) Global Patient Advocate Summit in Lisbon! Neuroendocrine Cancer UK CEO, Cathy Bouvier is at the conference and will be bringing us...